3Kobashi Y, Yoshida K, Miyashita N, et al. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates[J]. J Infect Chemother,2006,12:195-202.
4Dye C,Watt CJ,Bleed DM,et al. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence ,prevalence,and deaths globally [ J ]. Jama, 2005,293 : 2767-2775.
5Vallejo AN. Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged[J]. Immunol Res,2006, 36: 221-228.
6Geng E,Kreiswirth B,Burzynki J,Schluger NW. Clinical and radiographic correlates of primary and reactivation tuberculosis:a molecular epidemiology study [ J ]. Jama, 2005,293 : 2740-2745.
5Couser J I,GIassroth J.Tuberculosis.An epidemic in older adults[J].Clinics in Chest Medicine,1993,14(9):491-499.
6World Health Organization.耐药结核病规划管理指南(2008紧急修订版)[M].中国疾病预防控制中心结核病防治临床中心,世界卫生组织结核病研究培训合作中心,中华医学会结核病学分会,译.北京:中国疾病预防控制中心结核病防治临床中心,2008:1-6.
7Resende Co T,Hirsch C S,Toossi Z,et al.Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy[J].Clin Exp Immun,2007,147(1):45-52.
8Lin H H,Murray M,Cohen T,et al.Effects of smoking and solid-fuel use on COPD,lung cancer,and tuberculosis in China:a time-based,multiple risk factor,modeling study[J].Lancet,2008,372(9648):1473-1483.
9Wallis R S,Pai M,Menzies D,et al.Biomarkers and diagnostics for tuberculosis:progress,needs,and translation into practice[J].Lancet,2010,375(9729):1920-1937.